Breast tumor characteristics as predictors of mammographic detection: Comparison of interval- and screen-detected cancers

被引:218
作者
Porter, PL
El-Bastawissi, AY
Mandelson, MT
Lin, MG
Khalid, N
Watney, EA
Cousens, L
White, D
Taplin, S
White, E
机构
[1] Fred Hutchinson Canc Res Ctr, Program Canc Biol, Div Human Biol, Seattle, WA 98109 USA
[2] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
[3] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[4] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA
[5] Grp Hlth Cooperat Puget Sound, Dept Radiol, Seattle, WA 98101 USA
[6] Univ Washington, Dept Family Med, Seattle, WA 98195 USA
关键词
D O I
10.1093/jnci/91.23.2020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Although mammographic screening is useful for detecting early breast cancer, some tumors are detected in the interval between screening examinations. This study attempted to characterize fully the tumors detected in the two different manners. Methods: Our study utilized a case-control design and involved a cohort of women undergoing mammographic screening within the defined population of a health maintenance organization (the Group Health Cooperative of Puget Sound). Women were classified as having "interval" or "interval-detected'' cancers (n = 150) if their diagnosis was made within 24 months after a negative-screening mammogram or one that indicated a benign condition. Cancers were classified as "screen detected" (n = 279) if the diagnosis occurred after a positive assessment by screening mammography. Tumors from women in each group were evaluated for clinical presentation, histology, proliferative characteristics, and expression of hormone receptors, p53 tumor suppressor protein, and c-erbB-2 protein. Results: Interval-detected cancers occurred more in younger women and were of larger tumor size than screen-detected cancers. In unconditional logistic regression models adjusted for age and tumor size, tumors with lobular (odds ratio [OR] = 1.9; 95% confidence interval [CI] = 0.9-4.2) or mucinous (OR = 5.5; 95% CI=1.5-19.4) histology, high proliferation (by either mitotic count [OR = 2.9; 95% CI = 1.5-5.7] or Ki-67 antigen expression [OR = 2.3; 95% CI = 1.3-4.1]), high histologic grade (OR = 2.1; 95% CI = 1.2-4.0), high nuclear grade (OR = 2.0; 95% Cf = 1.0-3.7), or negative estrogen receptor status (OR 1.8; 95% CI = 1.0-3.1) were more likely to surface in the interval between screening examinations. Tumors with tubular histology (OR = 0.2; 95% CI = 0.0-0.8) or with a high percentage of in situ components (50%) (OR = 0.5; 95% CI = 0.2-1.2) were associated with an increased likelihood of screen detection. Conclusions: Our data from a large group of women in a defined population indicate that screening mammography may miss tumors of lobular or mucinous histology and some rapidly proliferating, high-grade tumors.
引用
收藏
页码:2020 / 2028
页数:9
相关论文
共 50 条
  • [1] INVASIVE LOBULAR CARCINOMA - MAMMOGRAPHIC PATTERN
    ADLER, OB
    ENGEL, A
    [J]. FORTSCHRITTE AUF DEM GEBIETE DER RONTGENSTRAHLEN UND DER NEUEN BILDGEBENDEN VERFAHREN, 1990, 152 (04): : 460 - 462
  • [2] ALBAIN KS, 1994, MONOGR NATL CANC I, V16, P35
  • [3] American College of Radiology, 1993, AM COLL RAD BREAST I
  • [4] [Anonymous], MAN STAG CANC
  • [5] Bast RC, 1996, J CLIN ONCOL, V14, P2843
  • [6] HISTOLOGICAL GRADING AND PROGNOSIS IN BREAST CANCER - A STUDY OF 1409 CASES OF WHICH 359 HAVE BEEN FOLLOWED FOR 15 YEARS
    BLOOM, HJG
    RICHARDSON, WW
    [J]. BRITISH JOURNAL OF CANCER, 1957, 11 (03) : 359 - &
  • [7] Brekelmans CT, 1996, CANCER, V78, P1220, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1220::AID-CNCR8>3.0.CO
  • [8] 2-D
  • [9] INTERVAL BREAST CANCERS IN THE SCREENING MAMMOGRAPHY PROGRAM OF BRITISH-COLUMBIA - ANALYSIS AND CLASSIFICATION
    BURHENNE, HJ
    BURHENNE, LW
    GOLDBERG, F
    HISLOP, TG
    WORTH, AJ
    REBBECK, PM
    KAN, L
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 1994, 162 (05) : 1067 - 1071
  • [10] A CLINICALLY EFFECTIVE BREAST-CANCER SCREENING-PROGRAM CAN BE COST-EFFECTIVE, TOO
    CARTER, AP
    THOMPSON, RS
    BOURDEAU, RV
    ANDENES, J
    MUSTIN, H
    STRALEY, H
    [J]. PREVENTIVE MEDICINE, 1987, 16 (01) : 19 - 34